Executive Director Emeritus, The North American Menopause Society
Obstetrics & Gynecology
Dr. Margery L. Gass, MD
|
|
Give Review
Margery L. Gass, MD works in the field of Obstetrics & Gynecology. She studied medicine at University Hospital - University of Cincinnati College of Medicine. She received 2 awards: "Whos Who in Medicine and Healthcare" and "Top MD". Doctor Margery L. Gass, MD is a published doctor as well. She has 66 publications published. The latest was: Military Generation and Its Relationship to Mortality in Women Veterans in the Women's Health Initiative. She accepts Medicare payments and is registered with Medicare.gov.
Publications
- Vasomotor Symptoms and Quality of Life Among Veteran and Non-Veteran Postmenopausal Women.
- Military Generation and Its Relationship to Mortality in Women Veterans in the Women's Health Initiative.
- Estrogen Plus Progestin and Lung Cancer: Follow-up of the Women's Health Initiative Randomized Trial.
- Comparison of Fracture Risk Prediction by the US Preventive Services Task Force Strategy and Two Alternative Strategies in Women 50-64 Years Old in the Women's Health ...
- Risk factors for endometrial cancer in black and white women: a pooled analysis from the epidemiology of endometrial cancer consortium (E2C2).
- Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making: a clinical decision-support tool from The North American ...
- Why the product labeling for low-dose vaginal estrogen should be changed.
- Genitourinary Syndrome of Menopause: New Terminology for Vulvovaginal Atrophy from the International Society for the Study of Women's Sexual Health and The North Ameri...
- Osteoporosis Screening in Postmenopausal Women 50-64 Years-Old: Comparison of U.S. Preventive Services Task Force Strategy and Two Traditional Strategies in the Women'...
- Obesity and Late-Age Survival Without Major Disease or Disability in Older Women.
- Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women's Health Initiative Randomized Trials.
- Clinical Corner: a new feature in Menopause.
- Relationship between hysterectomy and admixture in African American women.
- Bone turnover marker profile in relation to the Menstrual cycle of premenopausal healthy women.
- Bone mineral density (BMD) assessment of central skeletal sites from peripheral BMD and ultrasonographic measurements: an improved solution employing age and weight in...
- Review of treatment modalities for postmenopausal Osteoporosis.
- One way to serve the post-menopausal patient.
- Putting the latest data into practice: case studies and clinical considerations in menopausal management.
- Testosterone for low libido in postmenopausal women not taking estrogen.
- Preventing Osteoporosis-related fractures: an overview.
- Fetal-maternal bleed in the second trimester of pregnancy. A report of two cases.
- Management of problems during Menopause.
- Hormone replacement for the new millennium.
- Multiple therapies for vaginal bleeding secondary to large Uterine myomas.
- Concerns about published data from the estrogen-progestin (HT) arm of the WHI.
- Calcium plus vitamin D supplementation and the risk of colorectal cancer.
- Alternatives for women through Menopause.
- Estrogen therapy and coronary-artery calcification.
- Hormonal replacement therapy.
- Identifying meaningful differences in vasomotor symptoms among menopausal women.
- Venous thrombosis and conjugated equine estrogen in women without a uterus.
- Osteoporosis and rate of bone loss among postmenopausal survivors of breast cancer.
- Impact of WHI conclusions and ACOG guidelines on clinical practice.
- The relationship between cognitive function and physical performance in older women: results from the women's health initiative memory study.
- Calcium plus vitamin D supplementation and the risk of fractures.
- Raloxifene.
- Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial.
- Fracture risk among breast cancer survivors: results from the Women''s Health Initiative Observational Study.
- The effect of low-dose conjugated equine estrogens and cyclic MPA on bone density.
- Highlights from the latest WHI publications and the latest North American Menopause Society position statement on use of menopausal hormone therapy.
- Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial.
- Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial.
- Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women''s Health Initiative randomized controlled trial.
- Reanalysis of the Women''s Health Initiative oral contraceptive data reveals no evidence of delayed cardiovascular benefit.
- Antiepileptic drug use, falls, fractures, and BMD in postmenopausal women: findings from the women's health initiative (WHI).
- Urinary tract stone occurrence in the Women's Health Initiative (WHI) randomized clinical trial of calcium and vitamin D supplements.
- Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial.
- Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women's Health Initiative calcium-vitamin D randomized controlled trial.
- Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial.
- Breast cancer after use of estrogen plus progestin in postmenopausal women.
- Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial.
- Symptom experience after discontinuing use of estrogen plus progestin.
- Vasomotor symptoms and coronary artery calcium in postmenopausal women.
- Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin.
- Effects of conjugated equine estrogen on health-related quality of life in postmenopausal women with hysterectomy: results from the Women''s Health Initiative Randomiz...
- Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women''s Health Initiative Randomized Trial.
- Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women.
- Menopausal symptom experience before and after stopping estrogen therapy in the Women's Health Initiative randomized, placebo-controlled trial.
- Patterns and predictors of Sexual activity among women in the Hormone Therapy trials of the Women's Health Initiative.
- The effect of calcium plus vitamin D on risk for invasive cancer: results of the Women''s Health Initiative (WHI) calcium plus vitamin D randomized clinical trial.
- Evaluation of bazedoxifene/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile.
- Body mass index does not influence response to treatment, nor does body weight change with lower doses of conjugated estrogens and medroxyprogesterone acetate in early...
- Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women''s Health Initiative Memory Study: a randomized controlled trial.
- The effects of combined raloxifene and oral estrogen on vasomotor symptoms and endometrial safety.
- Spring cleaning at NAMS: the amended and restated code of regulations.
Schools
University of Cincinnati Main Campus
University Hospital
Procedures Preformed
- Colposcopy
- Contraceptive Management
- Gynecologic Cancer Screening
- Hysteroscopy
- View All
Conditions Treated
- Atrophic Vaginitis
- Hyperlipidemia
- Mastodynia
- Menstrual Disorders (incl. Dysmenorrhea)
- View All
Doctors Specialties
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- Whos Who in Medicine and Healthcare
- Top MD
Education
-
University Hospital - University of Cincinnati College of Medicine -
University of Cincinnati College of Medicine
Drug Facts
| NPI NUMBER | 1871506840 | |
| NPPES Provider LastName | GASS | |
| NPPES Provider FirstName | MARGERY | |
| NPPES Provider ZIPCode | 441950001 | |
| NPPES Provider State | OH | |
| Specialty Description | Obstetrics/Gynecology | |
| Total Claim Count | 21.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1871506840 |
| Last Name Of The Provider | GASS |
| First Name Of The Provider | MARGERY |
| View All |
Similar Doctors
|
|
Dr. Jane C. Kappus, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John E. Jelovsek, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julierut Tantibhedhyangkul, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Betsy Patterson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pamela J. Hruby, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Megan E. Buechel, MD |
|
|
Dr. Kelly S. Gibson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thaddeus Waters, MD
This Doctor is OpenDoctor Recommended.
|